MAINTENANCE OF HEALED EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (ERD)

Clinical trials for MAINTENANCE OF HEALED EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (ERD) explained in plain language.

Never miss a new study

Get alerted when new MAINTENANCE OF HEALED EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (ERD) trials appear

Sign up with your email to follow new studies for MAINTENANCE OF HEALED EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (ERD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new pill prevent esophageal damage from returning?

Disease control Not yet recruiting

This trial tests whether an experimental drug called JP-1366 can prevent the return of erosive esophagitis in people whose condition has already healed. About 384 adults aged 19 to 75 will take either JP-1366 or the standard drug lansoprazole daily for 24 weeks. The goal is to se…

Matched conditions: MAINTENANCE OF HEALED EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (ERD)

Phase: PHASE3 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC

MAINTENANCE OF HEALED EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (ERD)

Get alerted when new MAINTENANCE OF HEALED EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (ERD) trials appear

Can a new pill prevent esophageal damage from returning?